News

Humana losing star ratings is a big set-back that lead to its share price falling by 7.5% before paring losses.
Shares of Humana Inc. (NYSE: HUM) are trading lower Friday after the company lost a legal battle over Medicare bonus payments ...
The company's stock has fallen sharply since it announced the Medicare ratings downgrade. On Oct. 1, the stock opened at $315. After the ruling Friday, the company's stock was down 2% to $219.04.
It’s a stunning loss for the insurer, which sued the government late last year after its star ratings plummeted for 2025.
Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.
View the latest Humana Inc. (HUM) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Humana (HUM) stock falls as the company loses a lawsuit over its 2025 Medicare Star Ratings cut. Read more here.
Humana Inc. (NYSE:HUM) saw its share price drop to a 52-week low of $212.33, reflecting a steep 42.3% decline over the past ...
Humana Inc. lost its lawsuit seeking to reverse cuts to its Medicare bonus payments, a blow for the insurer that had hoped ...
Shares of Humana Inc. HUM shed 1.33% to $223.55 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.54% to 6,297.36 and the ...
Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $280.75, accompanied by a ...
The Cigna Group's fundamentals are solid, but the stock is fairly valued versus peers, not a bargain. Click here to find out ...